These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29613843)

  • 1. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
    Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin.
    Shyn PB; Cubre AJ; Catalano PJ; Lee LK; Hyun H; Tuncali K; Seol JG; Levesque VM; Gerbaudo VH; Kapur T; Chao RT; Silverman SG
    Abdom Radiol (NY); 2021 Jul; 46(7):3437-3447. PubMed ID: 33606061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
    Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate Postablation
    Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
    J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
    Yan Z; Khorasani R; Levesque VM; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1618-1625. PubMed ID: 33175240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
    Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
    J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
    Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
    J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition.
    Shyn PB; Tatli S; Sahni VA; Sadow CA; Forgione K; Mauri G; Morrison PR; Catalano PJ; Silverman SG
    Clin Radiol; 2014 Apr; 69(4):410-5. PubMed ID: 24411824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time US-
    Mauri G; Gennaro N; De Beni S; Ierace T; Goldberg SN; Rodari M; Solbiati LA
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):60-68. PubMed ID: 30288593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation.
    Tewari SO; Petre EN; Osborne J; Sofocleous CT
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1704-1706. PubMed ID: 23839009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.
    Ryan ER; Sofocleous CT; Schöder H; Carrasquillo JA; Nehmeh S; Larson SM; Thornton R; Siegelbaum RH; Erinjeri JP; Solomon SB
    Radiology; 2013 Jul; 268(1):288-95. PubMed ID: 23564714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split-Dose
    Zhao JM; Gusman M; Peacock JG; Wickley AB; Banks KP
    J Nucl Med Technol; 2019 Mar; 47(1):88-89. PubMed ID: 30683689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.
    Cazzato RL; Garnon J; Ramamurthy N; Tsoumakidou G; Imperiale A; Namer IJ; Bachellier P; Caudrelier J; Rao P; Koch G; Gangi A
    Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1315-21. PubMed ID: 27048487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel CT to Cone-Beam CT Registration Method Enables Immediate Real-Time Intraprocedural Three-Dimensional Assessment of Ablative Treatments of Liver Malignancies.
    Solbiati M; Passera KM; Goldberg SN; Rotilio A; Ierace T; Pedicini V; Poretti D; Solbiati L
    Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1049-1057. PubMed ID: 29492634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Tumor Ablation Procedure Duration and Estimated Patient Radiation Dose: Comparing Positron Emission Tomography/CT and CT Guidance.
    Hu EY; Levesque VM; Bay CP; Seol JG; Shyn PB
    J Vasc Interv Radiol; 2020 Jul; 31(7):1052-1059. PubMed ID: 32534979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases.
    Khandani AH; Calvo BF; O'Neil BH; Jorgenson J; Mauro MA
    AJR Am J Roentgenol; 2007 Nov; 189(5):1199-202. PubMed ID: 17954661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.
    Venkatesan AM; Kadoury S; Abi-Jaoudeh N; Levy EB; Maass-Moreno R; Krücker J; Dalal S; Xu S; Glossop N; Wood BJ
    Radiology; 2011 Sep; 260(3):848-56. PubMed ID: 21734159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
    Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
    J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
    Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
    J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].
    Liao WJ; Wu HB; Chen JZ; Shi M; You CX; Wang QS
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1641-2. PubMed ID: 19726317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.